Cargando…
C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions
Several studies have associated the presence of residual insulin secretion capability (also referred to as being C-peptide positive) with lower risk of insulin-induced hypoglycemia in patients with type 1 diabetes (T1D), although the reason is unclear. We tested the hypothesis that C-peptide infusio...
Autores principales: | Moore, Mary Courtney, Warner, Shana O., Dai, Yufei, Sheanon, Nicole, Smith, Marta, Farmer, Ben, Cason, Rebecca L., Cherrington, Alan D., Winnick, Jason J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262495/ https://www.ncbi.nlm.nih.gov/pubmed/34003799 http://dx.doi.org/10.1172/jci.insight.148997 |
Ejemplares similares
-
Short-term fasting lowers glucagon levels under euglycemic and hypoglycemic conditions in healthy humans
por: Warner, Shana O., et al.
Publicado: (2023) -
PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
por: Eyupoglu, Nesrin Damla, et al.
Publicado: (2022) -
Acute effects of euglycemic‐hyperinsulinemia on myocardial contractility in male mice
por: Tadinada, Satya Murthy, et al.
Publicado: (2022) -
Liver Glycogen Loading Dampens Glycogen Synthesis Seen in Response to Either Hyperinsulinemia or Intraportal Glucose Infusion
por: Winnick, Jason J., et al.
Publicado: (2013) -
Euglycemic Hyperinsulinemia Alters the Response to Orthostatic Stress in Older Adults With Type 2 Diabetes
por: Madden, Kenneth M., et al.
Publicado: (2008)